Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset
Objective: To evaluate the significance of antibodies against cyclic citrullinated peptide (anti-CCP) and rheumatoid factors (RFs), before the onset of rheumatoid arthritis and when presenting as early disease (baseline), for disease activity and progression. Methods: 93 of a cohort of 138 patients...
Published in: | Annals of the Rheumatic Diseases |
---|---|
Main Authors: | , , , , , , |
Format: | Text |
Language: | English |
Published: |
BMJ Publishing Group Ltd
2006
|
Subjects: | |
Online Access: | http://ard.bmj.com/cgi/content/short/65/4/453 https://doi.org/10.1136/ard.2005.041376 |
id |
fthighwire:oai:open-archive.highwire.org:annrheumdis:65/4/453 |
---|---|
record_format |
openpolar |
spelling |
fthighwire:oai:open-archive.highwire.org:annrheumdis:65/4/453 2023-05-15T17:45:00+02:00 Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset Berglin, E Johansson, T Sundin, U Jidell, E Wadell, G Hallmans, G Rantapää-Dahlqvist, S 2006-04-01 00:00:00.0 text/html http://ard.bmj.com/cgi/content/short/65/4/453 https://doi.org/10.1136/ard.2005.041376 en eng BMJ Publishing Group Ltd http://ard.bmj.com/cgi/content/short/65/4/453 http://dx.doi.org/10.1136/ard.2005.041376 Copyright (C) 2006, BMJ Publishing Group Ltd Extended reports TEXT 2006 fthighwire https://doi.org/10.1136/ard.2005.041376 2015-02-28T19:54:31Z Objective: To evaluate the significance of antibodies against cyclic citrullinated peptide (anti-CCP) and rheumatoid factors (RFs), before the onset of rheumatoid arthritis and when presenting as early disease (baseline), for disease activity and progression. Methods: 93 of a cohort of 138 patients with early rheumatoid arthritis (<12 months of symptoms) had donated blood before symptoms of rheumatoid arthritis (defined as pre-patients) and were identified from among blood donors within the Medical Biobank of northern Sweden. Disease activity (erythrocyte sedimentation rate (ESR), C reactive protein, joint score, global visual analogue scale) and radiological destruction in hands and feet (Larsen score) were assessed at baseline and after two years. Anti-CCP antibodies and RFs were analysed using enzyme immunoassays. HLA shared epitope (SE) alleles (DRB1*0401/0404) were identified. Results: Patients with anti-CCP antibodies before disease onset had significantly higher Larsen score at baseline and after two years. In multiple regression analyses baseline values of anti-CCP/IgA-RF/IgG-RF/IgM-RF, swollen joint count, and Larsen score significantly predicted radiological outcome at two years. In logistic regression analyses, baseline values of anti-CCP antibodies/IgA-RF, therapeutic response at six months, and swollen joint count/ESR significantly predicted radiological progression after two years. The baseline titre of anti-CCP antibodies was higher in patients with radiological progression and decreased significantly in those with response to therapy. SE allele carriage was associated with a positive test for anti-CCP antibodies in pre-patients and in early rheumatoid arthritis. Conclusions: Presence of anti-CCP antibodies before disease onset is associated with more severe radiological damage. The titre of anti-CCP antibodies is related to disease severity. Text Northern Sweden HighWire Press (Stanford University) Annals of the Rheumatic Diseases 65 4 453 458 |
institution |
Open Polar |
collection |
HighWire Press (Stanford University) |
op_collection_id |
fthighwire |
language |
English |
topic |
Extended reports |
spellingShingle |
Extended reports Berglin, E Johansson, T Sundin, U Jidell, E Wadell, G Hallmans, G Rantapää-Dahlqvist, S Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
topic_facet |
Extended reports |
description |
Objective: To evaluate the significance of antibodies against cyclic citrullinated peptide (anti-CCP) and rheumatoid factors (RFs), before the onset of rheumatoid arthritis and when presenting as early disease (baseline), for disease activity and progression. Methods: 93 of a cohort of 138 patients with early rheumatoid arthritis (<12 months of symptoms) had donated blood before symptoms of rheumatoid arthritis (defined as pre-patients) and were identified from among blood donors within the Medical Biobank of northern Sweden. Disease activity (erythrocyte sedimentation rate (ESR), C reactive protein, joint score, global visual analogue scale) and radiological destruction in hands and feet (Larsen score) were assessed at baseline and after two years. Anti-CCP antibodies and RFs were analysed using enzyme immunoassays. HLA shared epitope (SE) alleles (DRB1*0401/0404) were identified. Results: Patients with anti-CCP antibodies before disease onset had significantly higher Larsen score at baseline and after two years. In multiple regression analyses baseline values of anti-CCP/IgA-RF/IgG-RF/IgM-RF, swollen joint count, and Larsen score significantly predicted radiological outcome at two years. In logistic regression analyses, baseline values of anti-CCP antibodies/IgA-RF, therapeutic response at six months, and swollen joint count/ESR significantly predicted radiological progression after two years. The baseline titre of anti-CCP antibodies was higher in patients with radiological progression and decreased significantly in those with response to therapy. SE allele carriage was associated with a positive test for anti-CCP antibodies in pre-patients and in early rheumatoid arthritis. Conclusions: Presence of anti-CCP antibodies before disease onset is associated with more severe radiological damage. The titre of anti-CCP antibodies is related to disease severity. |
format |
Text |
author |
Berglin, E Johansson, T Sundin, U Jidell, E Wadell, G Hallmans, G Rantapää-Dahlqvist, S |
author_facet |
Berglin, E Johansson, T Sundin, U Jidell, E Wadell, G Hallmans, G Rantapää-Dahlqvist, S |
author_sort |
Berglin, E |
title |
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
title_short |
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
title_full |
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
title_fullStr |
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
title_full_unstemmed |
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset |
title_sort |
radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by iga-rf at disease onset |
publisher |
BMJ Publishing Group Ltd |
publishDate |
2006 |
url |
http://ard.bmj.com/cgi/content/short/65/4/453 https://doi.org/10.1136/ard.2005.041376 |
genre |
Northern Sweden |
genre_facet |
Northern Sweden |
op_relation |
http://ard.bmj.com/cgi/content/short/65/4/453 http://dx.doi.org/10.1136/ard.2005.041376 |
op_rights |
Copyright (C) 2006, BMJ Publishing Group Ltd |
op_doi |
https://doi.org/10.1136/ard.2005.041376 |
container_title |
Annals of the Rheumatic Diseases |
container_volume |
65 |
container_issue |
4 |
container_start_page |
453 |
op_container_end_page |
458 |
_version_ |
1766147701169192960 |